PrecISE: Precision Medicine in Severe Asthma: An adaptive platform trial with biomarker ascertainment.
PrecISE: Precision Medicine in Severe Asthma: An adaptive platform trial with biomarker ascertainment. J Allergy Clin Immunol. 2021 05; 147(5):1594-1601.